BCBo Chen

Bo Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Chen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Kankan Zhao

    Department of thyroid and breast surgery, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei, China

    1 shared publication
  • Kankan Zhao

    Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, P.R. China

    1 shared publication
  • Wen-Liang Lu

    Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Huazhong University of Science and Technology, Wuhan, China

    1 shared publication
  • Wenliang Lu

    Department of thyroid and breast surgery, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei, China

    1 shared publication
  • Yuan Master Zheng

    Department of Thyroid and Breast Surgery, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, P.R. China

    1 shared publication
  • Yuan Zheng

    Department of thyroid and breast surgery, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei, China

    1 shared publication

Latest Publications

  • Open Access

    Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer

    by Kankan Zhao, Yuan Zheng, Wenliang Lu, Bo Chen

    Background: Ubiquitination-related genes (URGs) are important biomarkers and therapeutic targets in cancer. However, URG prognostic prediction models have not been established in triple-negative breast cancer (TNBC) before. Our study aimed to explore the roles of URGs in TNBC.Methods: The Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) and the Gene Expression Omnibus (GEO) databases were used to identify URG expression patterns in TNBC. Non-negative matrix factorization (NMF) analysis was used to cluster TNBC patients. The least absolute shrinkage and selection operator (LASSO) analysis was used to construct the multi-URG signature in the training set (METABRIC). Next, we evaluated and validated the signature in the test set (GSE58812). Finally, we evaluated the immune-related characteristics to explore the mechanism.Results: We identified four clusters with significantly different immune signatures in TNBC based on URGs. Then, we developed an 11-URG signature with good performance for patients with TNBC. According to the 11-URG signature, TNBC patients can be classified into a high-risk group and a low-risk group with significantly different overall survival. The predictive ability of this 11-URG signature was favorable in the test set. Moreover, we constructed a nomogram comprising the risk score and clinicopathological characteristics with favorable predictive ability. All of the immune cells and immune-related pathways were higher in the low-risk group than in the high-risk group.Conclusion: Our study indicated URGs might interact with the immune phenotype to influence the development of TNBC, which contributes to a further understanding of molecular mechanisms and the development of novel therapeutic targets for TNBC.


  • Open Access

    Identification of a novel ubiquitination related gene signature for patients with breast cancer

    by Yuan Master Zheng, Wenliang Master Lu, Bo Chen, Kankan Zhao

    Ubiquitination related genes (URGs) are important biomarkers and therapeutic targets in cancer. However, URG prognostic prediction models have not been established in breast cancer (BC) before. Our study aimed to identify URGs to serve as potential prognostic indicators in patients with BC.The URGs were downloaded from the ubiquitin and ubiquitin-like conjugation database. GSE42568 and The Cancer Genome Atlas were exploited to screen differentially expressed URGs in BC. The univariate Cox proportional hazards regression analysis, least absolute shrinkage and selection operator analysis, and multivariate Cox proportional hazards regression analysis were employed to construct multi-URG signature in the training set (GSE42568). Kaplan–Meier curve and log-rank method analysis, and ROC curve were applied to validate the predictive ability of the multi-URG signature in BC. Next, we validated the signature in test set (GSE20685). Finally, we performed GSEA analysis to explore the mechanism.We developed a 4-URG (CDC20, PCGF2, UBE2S, and SOCS2) signature with good performance for patients with BC. According to this signature, BC patients can be classified into a high-risk and a low-risk group with significantly different overall survival. The predictive ability of this signature was favorable in the test set. Univariate and multivariate Cox regression analysis showed that the 4-URG signature was independent risk factor for BC patients. GSEA analysis showed that the 4-URG signature may related to the function of DNA replication, DNA repair, and cell cycle.Our study developed a novel 4-URG signature as a potential indicator for BC.